
URGN CLASS ACTION: Invest in UroGen Pharma Ltd.? Contact BFA Law about the Pending Securities Fraud Class Action to ...
NEW YORK, June 12, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against UroGen Pharma Ltd. (NASDAQ: URGN) and certain of the Company’s senior executives for potential violations …